DOT vs. Non-DOT Drug Testing: Key Differences Employers Must Understand

The Core Distinction

DOT drug testing is governed by federal regulations — specifically 49 CFR Part 40 — and applies to employees in safety-sensitive transportation roles: commercial drivers (FMCSA), pilots (FAA), railroad workers (FRA), transit employees (FTA), pipeline workers (PHMSA), and mariners (USCG). Non-DOT testing covers every other type of workplace drug screening and is governed by employer policy and state law.

Mixing up these two categories — or using a non-DOT test when a DOT test is required — creates serious compliance exposure.

Specimen Type

DOT: Urine only. Period. No exceptions. Hair, saliva, or blood specimens are not permitted for federally regulated testing regardless of what the employer prefers.

Non-DOT: Employers may use urine, hair, oral fluid, or breath depending on the policy and applicable state laws.

Panel and Cutoff Levels

DOT: Must use the federal 5-panel: marijuana (THC), cocaine, opiates (including heroin), phencyclidine (PCP), and amphetamines/methamphetamines. Cutoff concentrations are federally mandated and cannot be altered. Expanded opioid testing (hydrocodone, oxycodone, hydromorphone, oxymorphone) was added in 2018.

Non-DOT: Employers can test for any substances they choose — 5-panel, 10-panel, 12-panel — at whatever cutoff levels they set. Many industries add benzodiazepines or fentanyl to their panels.

Collection Site Requirements

DOT: Collection must occur at a federally approved collection site following strict chain-of-custody procedures. The collector must be trained and proficient in DOT collection procedures. The specimen must be split into two vials (A and B) in the event of a retest request.

Non-DOT: Chain of custody is still best practice but is not federally mandated. Many employers use point-of-care (instant) tests for non-DOT purposes.

The MRO Process

DOT: Every non-negative result must be reviewed by a certified Medical Review Officer (MRO) before it is reported to the employer. The MRO contacts the donor directly to determine if there is a legitimate medical explanation. This process cannot be skipped.

Non-DOT: MRO review is not required, though many employers use it as a best practice to reduce legal exposure.

Marijuana — A Critical Note

Federal law (which governs DOT testing) still classifies marijuana as a Schedule I controlled substance. A positive marijuana result on a DOT test is a violation regardless of the driver's state of residence, medical card, or recreational use status. There is no accommodation for state-legal marijuana use under DOT regulations. Non-DOT employers in legal states may choose whether to enforce a marijuana-free policy.

Bottom Line for Employers

If any of your employees hold a CDL or operate in a federally regulated safety-sensitive role, those employees must receive DOT-compliant testing — full stop. Using a non-DOT test in place of a required DOT test does not satisfy the regulatory requirement and exposes you to significant FMCSA penalties. Contact our office if you are unsure which testing program applies to your workforce.